Steve brings a wealth of experience to Stream, joining from e-Therapeutics Ltd. His career began in The Wellcome Foundation, in R&D and Operations. He rose to become the Head of Project Management for the Wellcome Group, involved in all aspects of NCE and NBE development, driving the overall strategy, portfolio review and with full responsibility for budgets/financial control.
When Glaxo acquired Wellcome, Steve helped integrate the two R&D organisations. On completion, Steve joined the Boots Healthcare International team as Head of Development for OTC products in the respiratory/analgesic range of products, before moving to Merck Generics to become the Head of World Wide R&D, responsible for over 11 major sites and 1000 R&D staff. In 2007 Steve was part of the management team that successfully sold the Group to Mylan for over $7 billion. He has also worked for several Private Equity Groups including helping Apax partners prepare the US company Qualitest for its eventual sale to Endo.